Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0239 per EA under NDC 68382075910. Its NADAC has been published 585 times since Jun 10, 2015.
FDA first approved this application on Aug 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382075910
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203686FDA Approved
8/28/2014
TE Code
AB
On Market Since
12/9/2014
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 585 times since Jun 10, 2015, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0239 per EA |
|---|---|
| All-time high | $0.0387 (Jul 15, 2015) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0287 |
| Average price | $0.0284 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 585 |
| Tracking since | Jun 10, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0239 per EA (NDC 68382075910), effective Aug 19, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 36.3%. It has been tracked across 585 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Jun 10, 2015, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0387 (Jul 15, 2015), with a median of $0.0287 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 850 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 68382075910) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.